Ibandronate in profile: drug characteristics and clinical efficacy

Author： Reginster Jean-Yves Neuprez Audrey Bruyère Olivier

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.4, Iss.7, 2008-07, pp. : 941-951

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preclinical and Clinical Efficacy of the Bisphosphonate Ibandronate in Cancer Treatment

Current Clinical Pharmacology, Vol. 3, Iss. 1, 2008-01 ,pp. : 1-10

Bentham Science Publishers

Access to resources Recommend Favorite

Intravenous Ibandronate in the Treatment of Osteoporosis: Profile Report

By Croom Katherine F. Scott Lesley J.

Drugs & Aging, Vol. 23, Iss. 12, 2006-01 ,pp. : 997-1001

Adis International

Access to resources Recommend Favorite

Efficacy and safety of ibandronate in the treatment of neoplastic bone disease

By Pecherstorfer Martin

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 11, 2004-11 ,pp. : 2341-2350

Informa Healthcare

Access to resources Recommend Favorite

Ibandronate

By Dooley M. Balfour J.A.

Drugs, Vol. 57, Iss. 1, 1999-01 ,pp. : 101-108

Adis International

Access to resources Recommend Favorite

Ibandronate

By Adami S.

Drugs, Vol. 57, Iss. 1, 1999-01 ,pp. : 109-110

Adis International

Access to resources Recommend Favorite